Contraindications for taking Bedaquiline (Snaery)

Bedaquiline (Bedaquiline) is an important drug used to treat multidrug-resistant tuberculosis (MDR-TB), however, in some circumstances, there may be contraindications to its use. A contraindication refers to a situation in which the use of a drug is not recommended because the potential risks may outweigh the potential benefits. The following are some common contraindications for bedaquiline (Snaeryx) :

1.Allergic Reaction: It is contraindicated if the patient has an allergic reaction tobedaquiline (Snare) or any of its ingredients. Allergic reactions may include itchy skin, hives, difficulty breathing, throat tightening, chest tightness, anaphylactic shock and other symptoms. In the event of an allergic reaction, you should immediately stop using Bedaquiline (Sneril) and seek medical advice promptly.

2.Arrhythmia: Bedaquiline (Sneril) may affect the electrophysiological activity of the heart, leading to the occurrence of arrhythmia. Therefore, patients with severe cardiac arrhythmias (e.g., dilated tachycardia, atrial fibrillation, etc.) should avoid usebedaquiline (Sneril). During treatment, patients should receive regular electrocardiogram monitoring to monitor heart function and rhythm.

3.Cardiovascular disease: Bedaquiline (Snaery) may have adverse effects on the cardiovascular system, so use Bedaquiline (Snaery) in patients with severe cardiovascular diseases (such as heart failure, myocardial infarction, etc.) with caution. In these patients, use of bedaquiline (Snaeryx) may increase the risk of adverse cardiovascular events and even lead to serious complications.

4.Abnormal liver function: Bedaquiline (Snaery) is mainly metabolized by the liver in the body, so patients with severe liver dysfunction need to avoid its use. Abnormal liver function may cause the metabolism of bedaquiline (Snare) to slow down, thereby increasing the concentration of the drug in the body and increasing the toxicity of the drug and the occurrence of adverse reactions.

5.Visual impairment: Bedaquiline (Sneril) May cause visual disturbances such as decreased vision, blurring, or blindness. Therefore, patients with severe retinopathy or visual impairment should avoid useof bedaquiline (Snaery). During treatment, patients should receive regular eye exams to monitor vision and eye health.

6.Children and Adolescent Patients: Currently, the safety and effectiveness of bedaquiline (Sneril) in children and adolescents 18 years of age have not been fully established. Therefore, the use of bedaquiline (Snaeryx) in patients in this age group requires special caution and an assessment of the potential risks and benefits on a case-by-case basis.

7.Pregnant and lactating women: Bedaquiline (Sneril) may have adverse effects on the fetus and should be avoided by pregnant and lactating women. Use during pregnancyBedaquiline (Snaery)may increase the risk of abnormal fetal development and should be discontinued immediately during pregnancy or planned pregnancy.

In summary, bedaquiline (Snaery) contraindications include allergic reactions, cardiac arrhythmias, cardiovascular disease, abnormal liver function, visual impairment, children and adolescent patients, and pregnant and lactating women. Before using Bedaquiline (Snaery) , patients should carefully read the drug instructions, consult their doctor, and inform the doctor of their health status and medication history to avoid potential risks and adverse reactions.